NCT05027204 2022-10-13A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1/2 Unknown94 enrolled
NCT03652142 2018-08-29Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell CarcinomaAttikon HospitalUnknown50 enrolled